Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jan;83(1):256.e9-14.
doi: 10.1016/j.urology.2013.09.026. Epub 2013 Nov 13.

Urinary concentrations of aquaporin-1 and perilipin-2 in patients with renal cell carcinoma correlate with tumor size and stage but not grade

Jeremiah J Morrissey  1 , Jonathan Mobley  2 , Joseph Song  2 , Joel Vetter  2 , Jingqin Luo  3 , Sam Bhayani  2 , R Sherburne Figenshau  2 , Evan D Kharasch  4
Affiliations

Urinary concentrations of aquaporin-1 and perilipin-2 in patients with renal cell carcinoma correlate with tumor size and stage but not grade

Jeremiah J Morrissey et al. Urology. 2014 Jan.

Abstract

Objective: To evaluate the trends in urine aquaporin-1 (AQP1) and perilipin 2 (PLIN2) concentrations in patients with clear cell and papillary renal cell carcinoma (RCC), we determined the relationship between the urine concentration of these biomarkers and tumor size, grade, and stage.

Materials and methods: The biomarker concentrations were determined by sensitive and specific Western blot procedures normalized to the urine creatinine excretion. The analysis included 61 patients undergoing partial or radical nephrectomy for clear cell or papillary RCC and 43 age- and sex-matched control patients. Relationships between urine biomarker concentrations and tumor size, stage, and grade were assessed.

Results: Patients with RCC had 35-fold and 9-fold higher median urinary AQP1 and PLIN2 concentrations, respectively, compared with controls. Both tumor markers decreased after tumor resection to concentrations equivalent to those of controls. The sensitivity and specificity were both 100% for AQP1 and 92% and 100%, respectively, for PLIN2. A significant linear correlation was found between the tumor size and the prenephrectomy AQP1 (Spearman coefficient 0.78, P <.001) and PLIN2 (Spearman coefficient 0.69, P <.001) concentrations. A correlation was found for both markers with tumor stage (overall P = .030), when the stage was dependent primarily on the tumor size (stages T1 and T2), but not with stage T3, which reflected extrarenal spread. Neither marker showed a significant correlation with tumor grade.

Conclusion: AQP1 and PLIN2 were significantly increased in patients with clear cell and papillary RCC compared with controls. The preoperative urinary concentrations of these markers reflected the tumor size and stage.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Pre- and post-nephrectomy urine concentrations of AQP1 and PLIN2 in 47 patients with clear cell or papillary renal cell carcinoma.
Figure 2
Figure 2
Pre-nephrectomy urine concentrations of AQP1 (panels A and B) and PLIN2 (panels C and D) in 61 patients with clear cell or papillary renal cell carcinoma compared with tumor size (panels A and C) or tumor stage (panels B and D). Closed diamonds (panels A and C) indicate biomarker concentrations in patients with stage pT3 tumors. The dashed lines in panels A and C depict the linear correlation of biomarker concentration to tumor size while the polynomial correlation is depicted by the solid lines. The tumor stage analysis (B and D) includes data from 43 control patients with no known renal tumors.
See this image and copyright information in PMC

References

    1. Pantuck AJ, Zisman A, Belldegrun AS. The changing natural history of renal cell carcinoma. J Urol. 2001;166:1611–1623. - PubMed
    1. Hock LM, Lynch J, Balaji KC. Increasing incidence of all stages of kidney cancer in the last 2 decades in the United States: an analysis of surveillance, epidemiology and end results program data. J Urol. 2002;167:57–60. - PubMed
    1. Decastro GJ, McKiernan JM. Epidemiology, clinical staging, and presentation of renal cell carcinoma. Urol Clin North Am. 2008;35:581–592. vi. - PubMed
    1. Chow W-H, Dong LM, Devesa SS. Epidemiology and risk factors for kidney cancer. Nature reviews. Urology. 2010;7:245–257. - PMC - PubMed
    1. Nepple KG, Yang L, Grubb RL, et al. Population based analysis of the increasing incidence of kidney cancer in the United States: evaluation of age specific trends from 1975 to 2006. J Urol. 2012;187:32–38. - PubMed

Publication types